These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15545008)

  • 1. Flotillin-1 in the substantia nigra of the Parkinson brain and a predominant localization in catecholaminergic nerves in the rat brain.
    Jacobowitz DM; Kallarakal AT
    Neurotox Res; 2004; 6(4):245-57. PubMed ID: 15545008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain.
    Yamada M; Yamada M; Richelson E
    Neuroscience; 1995 Jan; 64(2):405-17. PubMed ID: 7700529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.
    Benisty S; Boissiere F; Faucheux B; Agid Y; Hirsch EC
    Neuroscience; 1998 Oct; 86(3):813-26. PubMed ID: 9692719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
    Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.
    Bossers K; Meerhoff G; Balesar R; van Dongen JW; Kruse CG; Swaab DF; Verhaagen J
    Brain Pathol; 2009 Jan; 19(1):91-107. PubMed ID: 18462474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain.
    Yamada M; Groshan K; Phung CT; Yamada M; Hisamitsu T; Richelson E
    Brain Res Mol Brain Res; 1997 Feb; 44(1):12-20. PubMed ID: 9030693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
    Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F
    Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: regional fiber vulnerability in the striatum and the olfactory tubercle.
    Ueda S; Aikawa M; Ishizuya-Oka A; Yamaoka S; Koibuchi N; Yoshimoto K
    Neuroscience; 2000; 95(2):389-98. PubMed ID: 10658618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.
    Chadi G; Cao Y; Pettersson RF; Fuxe K
    Neuroscience; 1994 Aug; 61(4):891-910. PubMed ID: 7838386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain.
    Pillot C; Heron A; Cochois V; Tardivel-Lacombe J; Ligneau X; Schwartz JC; Arrang JM
    Neuroscience; 2002; 114(1):173-93. PubMed ID: 12207964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.
    Counihan TJ; Penney JB
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):164-9. PubMed ID: 9703165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
    Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME
    J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
    Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cholecystokinin colocalize with dopamine in the human substantia nigra?
    Palacios JM; Savasta M; Mengod G
    Brain Res; 1989 May; 488(1-2):369-75. PubMed ID: 2743135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
    Anichtchik OV; Rinne JO; Kalimo H; Panula P
    Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T; Barroso-Chinea P; Rodríguez M
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.